STOCK TITAN

Trinity Biotech to Present at Emerging Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences acquisition
Rhea-AI Summary
Trinity Biotech plc (TRIB) will present virtually at the Emerging Growth Conference on March 7, 2024. The Company invites investors and analysts to attend its real-time, interactive presentation. Details of the presentation include the date, time, and registration link.
Positive
  • None.
Negative
  • None.

DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on March 7, 2024. The Company invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. Please see the presentation information below.

Presentation Details

Date:Thursday, March 7, 2024
Time:11:25 – 11:55 AM ET
Registration: https://goto.webcasts.com/starthere.jsp?ei=1650531&tp_key=ca9510e531&sti=trib

About Trinity Biotech Plc

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information, please see the Company's website: www.trinitybiotech.com

Contact:Trinity Biotech plc
Des Fitzgerald
(353)-1-2769800
LifeSci Partners, LLC
Eric Ribner
(1)-646-751-4363
E-mail investorrelations@trinitybiotech.com


Trinity Biotech plc will present at the Emerging Growth Conference on March 7, 2024.

The ticker symbol for Trinity Biotech plc is TRIB.

Individual and institutional investors, as well as advisors and analysts, are invited to attend the presentation.

You can register for the presentation at the following link: https://goto.webcasts.com/starthere.jsp?ei=1650531&tp_key=ca9510e531&sti=trib
Trinity Biotech Plc

NASDAQ:TRIB

TRIB Rankings

TRIB Latest News

TRIB Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Ireland
Bray

About TRIB

since its formation in 1992, trinity biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. the test kits manufactured by trinity biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. the company is also a significant provider of raw materials to the life sciences industry. trinity biotech, which has its headquarters in ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 80 countries around the world. it reaches this worldwide market by combining the